hasMolecularFunction
P68681
predicate
Indicates that an entity (typically a gene product or protein) performs or is associated with a specific molecular-level activity or function.
Observed surface forms (4)
- proteinFunction ×3
- hasMolecularFunctionViaPla ×2
- molecularFunctionOfProduct ×2
- hasCytoplasmicDomainFunction ×1
Sample triples (112)
| Subject | Object |
|---|---|
| ABC subfamily B | ATP binding ⓘ |
| ABC subfamily B | ATPase activity ⓘ |
| ABC subfamily B | transmembrane transporter activity ⓘ |
|
ABCG2 gene
surface form:
ABCG2
|
ATP-dependent transmembrane transporter activity ⓘ |
|
ABCG2 gene
surface form:
ABCG2
|
drug transmembrane transporter activity ⓘ |
|
ABCG2 gene
surface form:
ABCG2
|
xenobiotic-transporting ATPase activity ⓘ |
| Antennapedia complex | DNA-binding transcription factor activity ⓘ |
| BTK | ATP binding ⓘ |
| BTK | protein phosphorylation ⓘ |
| BTK | protein tyrosine kinase activity ⓘ |
| Bruton tyrosine kinase | ATP binding ⓘ |
| Bruton tyrosine kinase | protein tyrosine kinase activity ⓘ |
|
chromosome 9 open reading frame 72
surface form:
C9orf72
|
endosomal-lysosomal pathway regulation via predicate surface "proteinFunction" ⓘ |
|
chromosome 9 open reading frame 72
surface form:
C9orf72
|
regulation of autophagy via predicate surface "proteinFunction" ⓘ |
|
chromosome 9 open reading frame 72
surface form:
C9orf72
|
regulation of membrane trafficking via predicate surface "proteinFunction" ⓘ |
| CB2 receptor | G protein-coupled receptor activity ⓘ |
| CB2 receptor | cannabinoid receptor activity ⓘ |
| CD3 complex | signal transduction via predicate surface "hasCytoplasmicDomainFunction" ⓘ |
| CD32 | IgG binding ⓘ |
| CD32 | immune receptor activity ⓘ |
| CD340 | protein tyrosine kinase activity ⓘ |
| CD340 | transmembrane receptor activity ⓘ |
| CD38 | ADP-ribosyl cyclase activity ⓘ |
| CD38 | NAD glycohydrolase activity ⓘ |
| CD38 | cyclic ADP-ribose hydrolase activity ⓘ |
| CDK6 | ATP binding ⓘ |
| CDK6 | cyclin-dependent protein serine/threonine kinase activity ⓘ |
| CDK6 | protein serine/threonine kinase activity ⓘ |
| CYP1A2 | monooxygenase activity ⓘ |
| CYP1A2 | oxidoreductase activity ⓘ |
| CYP2C19 | monooxygenase activity ⓘ |
| CYP2C19 | oxidoreductase activity ⓘ |
| CYP2C9 | monooxygenase activity ⓘ |
| CYP2C9 | oxidoreductase activity ⓘ |
| CYP3A5 | drug binding ⓘ |
| CYP3A5 | monooxygenase activity ⓘ |
| CYP3A5 | oxidoreductase activity ⓘ |
| Cdc28 | ATP binding ⓘ |
| Cdc28 | cyclin-dependent protein kinase activity ⓘ |
| Cdc28 | protein serine/threonine kinase activity ⓘ |
| ERBB3 | neuregulin binding ⓘ |
| ERBB3 | protein tyrosine kinase activity (impaired intrinsic kinase) ⓘ |
| ERBB3 | receptor activity ⓘ |
| ERBB4 | ATP binding ⓘ |
| ERBB4 | protein binding ⓘ |
| ERBB4 | protein tyrosine kinase activity ⓘ |
| ERBB4 | transmembrane receptor protein tyrosine kinase activity ⓘ |
|
GNAI3 gene (for Gαi3 in humans)
surface form:
GNAI3
|
GTP binding ⓘ |
|
GNAI3 gene (for Gαi3 in humans)
surface form:
GNAI3
|
GTPase activity ⓘ |
|
GNAI3 gene (for Gαi3 in humans)
surface form:
GNAI3
|
signal transducer activity ⓘ |